Skip to main content
Caplight Logo









Keragon

Keragon

Private
New York City, New YorkHealthcare & Life Scienceshttps://keragon.com

Last Round

Seed

Feb 12, 2025

Total Funding Raised

$10.5M

Company Overview

Keragon operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Seed round in February 2025.

Keragon is a healthcare technology company that provides an AI-powered, HIPAA-compliant, no-code automation platform to connect disparate systems and automate workflows for healthcare organizations.

Sector

Healthcare & Life Sciences

Verticals

Workflow Automation, EHR & EMR, Data Integration, Low-Code/No-Code, Compliance

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Keragon Comparables

Compare Keragon with similar companies based on industry and business-model similarity.

Keragon comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Awell
79%
Metriport
78%
Notable
76%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Keragon Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 12, 2025
Pre SeedJun 4, 2024
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Keragon Investors

Notable investors and investment history

Keragon investors
InvestorRounds
25madisonPre Seed
Upfront VenturesSeed
Afore CapitalSeed, Pre Seed
25m HealthSeed, Pre Seed
Focal VCSeed
focalSeed, Pre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 12, 2026

    Launched an AI-powered healthcare automation platform.

  • Feb 12, 2025

    $8M raised in Seed round.

Book a demo to see all signals

For institutional investors. Book with your work email.

Keragon Filings

Explore SEC and related filing metadata, where available.

Keragon filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Keragon's valuation, stock price, and market status.

Is Keragon a public or private company?

Keragon is a private company.

What is the current stock price of Keragon?

Keragon is a private company, so its shares have no public market price. Caplight tracks Keragon's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Keragon worth (valuation)?

Valuation information for Keragon is not publicly available.

Can I buy Keragon stock?

Keragon shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Keragon's last funding round?

Keragon's most recent funding round was Seed on February 12, 2025.

Who are the main investors in Keragon?

Key investors in Keragon include Upfront Ventures, Afore Capital, focal.

Will Keragon IPO soon?

No public IPO plans have been announced for Keragon.

How can I track Keragon secondary market activity?

Caplight tracks bids, offers, and trades in Keragon's shares on secondary markets.

Firmographic Details

HeadquartersNew York City, New York
Employee Range19
Year Founded2022
Last FundingFeb 12, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?